PMC:7799377 / 39198-39502 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T263","span":{"begin":149,"end":253},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"-line treatments for neuroinflammation involve IV immunoglobulin or plasma exchange, but IV immunoglobulin may increase the risk of thromboembolism. Furthermore, there is emerging concern of the possibility of microthrombosis in COVID-19 patients [121]. Third-line strategies for neuroinflammation in COV"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T190","span":{"begin":132,"end":147},"obj":"Phenotype"}],"attributes":[{"id":"A190","pred":"hp_id","subj":"T190","obj":"http://purl.obolibrary.org/obo/HP_0001907"}],"text":"-line treatments for neuroinflammation involve IV immunoglobulin or plasma exchange, but IV immunoglobulin may increase the risk of thromboembolism. Furthermore, there is emerging concern of the possibility of microthrombosis in COVID-19 patients [121]. Third-line strategies for neuroinflammation in COV"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1371","span":{"begin":238,"end":246},"obj":"Species"},{"id":"1378","span":{"begin":21,"end":38},"obj":"Disease"},{"id":"1379","span":{"begin":132,"end":147},"obj":"Disease"},{"id":"1380","span":{"begin":210,"end":225},"obj":"Disease"},{"id":"1381","span":{"begin":229,"end":237},"obj":"Disease"},{"id":"1382","span":{"begin":280,"end":297},"obj":"Disease"}],"attributes":[{"id":"A1371","pred":"tao:has_database_id","subj":"1371","obj":"Tax:9606"},{"id":"A1378","pred":"tao:has_database_id","subj":"1378","obj":"MESH:D020078"},{"id":"A1379","pred":"tao:has_database_id","subj":"1379","obj":"MESH:D013923"},{"id":"A1381","pred":"tao:has_database_id","subj":"1381","obj":"MESH:C000657245"},{"id":"A1382","pred":"tao:has_database_id","subj":"1382","obj":"MESH:D020078"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"-line treatments for neuroinflammation involve IV immunoglobulin or plasma exchange, but IV immunoglobulin may increase the risk of thromboembolism. Furthermore, there is emerging concern of the possibility of microthrombosis in COVID-19 patients [121]. Third-line strategies for neuroinflammation in COV"}